PORTFASTFLU
Portable automated test for fast detection and surveillance of influenza
| Coordinatore | GENEWAVE SAS
Organization address
address: RUE PIERRE FONTAINE 4 contact info |
| Nazionalità Coordinatore | France [FR] |
| Totale costo | 3˙933˙101 € |
| EC contributo | 2˙965˙874 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2007-A |
| Funding Scheme | CP-TP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-01-01 - 2010-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
GENEWAVE SAS
Organization address
address: RUE PIERRE FONTAINE 4 contact info |
FR (EVRY) | coordinator | 0.00 |
| 2 |
BIOSENSIA LIMITED
Organization address
address: MARDYKE PARADE 9 contact info |
IE (CORK) | participant | 0.00 |
| 3 |
CENTRE DE COOPERATION INTERNATIONAL EN RECHERCHE AGRONOMIQUE POUR LE DEVELOPPEMENT
Organization address
address: Rue Scheffer 42 contact info |
FR (PARIS) | participant | 0.00 |
| 4 |
FUNDACION GAIKER
Organization address
address: Parque Tecnologico de Zamudio, Edificio 202 contact info |
ES (ZAMUDIO) | participant | 0.00 |
| 5 |
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Organization address
address: PLAZA ASUA 1 contact info |
ES (SONDIKA) | participant | 0.00 |
| 6 |
IKERLAN S.COOP.
Organization address
address: Paseo J.M. Arizmendiarrieta 2 contact info |
ES (MONDRAGON) | participant | 0.00 |
| 7 |
THE NOTTINGHAM TRENT UNIVERSITY
Organization address
address: BURTON STREET contact info |
UK (NOTTINGHAM) | participant | 0.00 |
| 8 |
VIB
Organization address
address: Rijvisschestraat 120 contact info |
BE (ZWIJNAARDE - GENT) | participant | 0.00 |
| 9 |
WHATMAN INTERNATIONAL LIMITED
Organization address
address: SPRINGFIELD MILL JAMES WHATMAN WAY 15 contact info |
UK (MAIDSTONE) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The PORTFASTFLU’s objective is to develop and validate a rapid diagnostic test for influenza that will be used as point-of-care systems in developed and developing countries. Experts and international bodies agree that the rapid detection of influenza is vital in combating this major threat to human health. Nucleic acid analysis is the most appropriate assay scheme for both early detection and late surveillance of influenza, and is routinely used by WHO and OIE virology reference laboratories. PORTFASTFLU's consortium aims at developing and validating a Point of Care (POC) instrument which will integrate sample preparation, nucleic acid amplification, microarray hybridization and fluorescent readout in a single system. Reaching this challenging objective is possible through the combined expertise of the partners and comprises access to several selected enabling technologies: microfluidics, on-chip sample preparation, advanced microarray techniques and reading systems with ultimate sensitivity and selectivity, access to reference and field virus samples. This Bio-Micro knowledge converges in one single instrument, allowing rapid detection (less than an hour) and simultaneous identification of influenza A and B viruses (typing and sub-typing) at widespread POC with only basic skills. Furthermore, the project also aims at realizing this goal in a format that requires little supervision and is integrated in a portable compact monolithic system for deployment in the field. The consortium of 9 partners from 5 member states brings together the various expertises needed to reach these objectives, which match exactly those of the call Health 2.3.3-4: Innovative point-of-care diagnostic tests for influenza'
Altri progetti dello stesso programma (FP7-HEALTH)
MISMATCH2MODEL (2008)
Characterization and quantitative modeling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance
Read More